.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
US Army
Argus Health
Daiichi Sankyo
Cerilliant
Accenture
McKinsey
Fish and Richardson
Covington

Generated: June 23, 2017

DrugPatentWatch Database Preview

SEMPREX-D Drug Profile

« Back to Dashboard

What is the patent landscape for Semprex-d, and what generic Semprex-d alternatives are available?

Semprex-d is a drug marketed by Auxilium Pharms Llc and is included in one NDA.

The generic ingredient in SEMPREX-D is acrivastine; pseudoephedrine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acrivastine; pseudoephedrine hydrochloride profile page.

Summary for Tradename: SEMPREX-D

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SEMPREX-D at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc
SEMPREX-D
acrivastine; pseudoephedrine hydrochloride
CAPSULE;ORAL019806-001Mar 25, 1994RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SEMPREX-D

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Auxilium Pharms Llc
SEMPREX-D
acrivastine; pseudoephedrine hydrochloride
CAPSULE;ORAL019806-001Mar 25, 19944,501,893► Subscribe
Auxilium Pharms Llc
SEMPREX-D
acrivastine; pseudoephedrine hydrochloride
CAPSULE;ORAL019806-001Mar 25, 19944,650,807► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
QuintilesIMS
Moodys
Novartis
Citi
UBS
AstraZeneca
Daiichi Sankyo
Covington
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot